The pipeline

Orphinic Scientific connects researchers with experienced Project Managers, gives access to capital and provides drug development expertise.
Scroll to projects

Crucial steps we take

Project sourcing

  • Developed global network at the most prestigious Universities and Accelerators enables us to source the most promising undertakings
  • We source projects in our fields of expertise and cooperate with external consultants
  • By providing know-how, we usually invest in projects at significant discount

Project management

  • We invest in a single-product companies through SPV mechanisms with Orphinic Scientific as parent entity
  • We serve as know-how experts with successful track record in running clinical trials
  • We cooperate with an associated CRO which prioritizes our projects
  • We provide access to the capital for clinical phases
  • Our team prepares documentation and necessary materials to receive grants and nondilutive funding
  • We intend to terminate projects quickly if their hypothesis is not supported

Exit

  • After successful Phase I/II we seek to exit the investment targeting Big Pharma companies
  • We have experience in negotiating exit terms including exclusivity period, royalties, upfront payments and milestones

Orphinic has an advanced clinical pipeline with first exit projected in Q4 2024…

Q1’23
Q2’23
Q3’23
Q4’23
Q1’24
Q2’24
Q3’24
Q4’24
Q1’25
Q2’25
Q3’25
Q4’25
Q1’26
Q2’26

… and a strong pre-clinical pipeline driving long-term value

Q1’23
Q2’23
Q3’23
Q4’23
Q1’24
Q2’24
Q3’24
Q4’24
Q1’25
Q2’25
Q3’25
Q4’25

Do you want to get involved?

Get in touch
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram